ReviewCancers2022
Exploring the Evolving Scope of Neoadjuvant Immunotherapy in NSCLC.
John F Roller et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
12 papers cite it
this papercites it
ReviewCancers2022
John F Roller et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.